US Patent 11191757 Combination of pimavanserin and cytochrome P450 modulators
Patent 11191757 was granted and assigned to Acadia Pharmaceuticals on December, 2021 by the United States Patent and Trademark Office.
Name
# Contributions
Last Contribution
Find more entities like US Patent 11191757 Combination of pimavanserin and cytochrome P450 modulators
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
By using this site, you agree to our Terms of Service.